Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    jkj
    wrote on sidst redigeret af
    #1222

    tror 50 mill usd er for lavt sat, ud fra det faktum at ca 12000 ventes at dø hvert år af m.m i usa. mange af disse ville kunne drage fordel af dara, og 2 til 3 doser skal alle igennem for kunne fastslå effekt

    1 Reply Last reply
    0
    • J Offline
      J Offline
      jkj
      wrote on sidst redigeret af
      #1223

      tror mere på mcjean tal, efter at have regnet på det.

      1 Reply Last reply
      0
      • J Offline
        J Offline
        jkj
        wrote on sidst redigeret af
        #1224

        rettelse 8 ugentlige i 2 måneder, inden der afgøres om behandling stoppes, eller forsættes i længere intevaller

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1225

          Hver behandlingscyklus på 28 dage indebærer 4 infusioner https://www.clinicaltrials.gov/ct2/show/study/NCT02477891?term=daratumumab&rank=16&show_locs=Y#locn Hvis vi antager jkj's pris pr infusion og 12000 patienter bliver det 280 mio $ om måneden.

          1 Reply Last reply
          0
          • J Offline
            J Offline
            jkj
            wrote on sidst redigeret af
            #1226

            prisen er oplust af j&j her til aften

            1 Reply Last reply
            0
            • J Offline
              J Offline
              jkj
              wrote on sidst redigeret af
              #1227

              oplyst

              1 Reply Last reply
              0
              • J Offline
                J Offline
                jkj
                wrote on sidst redigeret af
                #1228

                http://www.newsmax.com/Health/Health-News/multiple-myeloma-drug-cancer-approved/2015/11/16/id/702389/

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  jkj
                  wrote on sidst redigeret af
                  #1229

                  Link Preview Image
                  DARZALEX® (daratumumab) Approved by U.S. FDA: First Human Anti-CD38 Monoclonal Antibody Available for the Treatment of Multiple Myeloma

                  First-in-class immunotherapy approved for multiple myeloma patients who have received three or more prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double refractory to a PI and immunomodulatory agent

                  favicon

                  Multivu (www.multivu.com)

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #1230

                    Hvis de 280 mio $ om måneden holder giver det med royalty 16% og en forsigtig p/e=20 en kurs på 1225 alene på Darzalex

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #1231

                      ... og kun USA

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        jkj
                        wrote on sidst redigeret af
                        #1232

                        self- vil nogle ikke vise respons på behandling, og vil hurtigt falde fra, men hvorfor skulle alle i målgruppen ikke have chancen, og hurtigt da de intet alternativ har.

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          jkj
                          wrote on sidst redigeret af
                          #1233

                          pt.

                          1 Reply Last reply
                          0
                          • D Offline
                            D Offline
                            dohk
                            wrote on sidst redigeret af
                            #1234

                            så er den første patient også blevet behandlet med subcutant dara.http://www.news-medical.net/news/20151105/Janssen-doses-first-patient-in-daratumumab-clinical-trial-using-Halozymes-ENHANZE-technology.aspx

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              dohk
                              wrote on sidst redigeret af
                              #1235

                              Men det drukner nok lidt i kursudviklingen i morgen.

                              1 Reply Last reply
                              0
                              • BudweisB Offline
                                BudweisB Offline
                                Budweis
                                wrote on sidst redigeret af
                                #1236

                                dohk - det er en gammel nyhed. Den er fra 5. nov.

                                1 Reply Last reply
                                0
                                • BudweisB Offline
                                  BudweisB Offline
                                  Budweis
                                  wrote on sidst redigeret af
                                  #1237

                                  Deutche er klar med første opjustering. "Completely de-risking daratumumab over the next 12 months would represent potential upside to our DCF-derived price target to DKK1000.
                                  "

                                  1 Reply Last reply
                                  0
                                  • Smadsen128S Offline
                                    Smadsen128S Offline
                                    Smadsen128
                                    wrote on sidst redigeret af
                                    #1238

                                    Lige de rigtige dag for affyring af Genmab raketten....både USA og Asien med pæne stigninger....glæder mig søm et lille barn til kl ni....god fornøjelse

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #1239

                                      God morgen. 🙂

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #1240

                                        God morGEN til en forhåbentlig spændende dag på børsen og på grønsværen.

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Repsac
                                          wrote on sidst redigeret af
                                          #1241

                                          Daratumumab is given once a week for the first two months of treatment, then the infusions wind down to once monthly in the second 6 months of the year, says a spokesperson for J&J. For the first full year--with a total of 23 doses given at a cost of $5,850 per infusion--the average monthly wholesale acquisition cost is $11,212, says J&J, or $135,550 for the first year. In year two, and any year thereafter, patients receive a total of 13 doses, for a monthly wholesale cost of $6,337, or $76,044

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger